LGL Partners’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,300
| Closed | -$14.5K | – | 101 |
|
|
2023
Q3 | $14.5K | Hold |
2,300
| – | – | ﹤0.01% | 93 |
|
|
2023
Q2 | $19.1K | Hold |
2,300
| – | – | ﹤0.01% | 99 |
|
|
2023
Q1 | $10.1K | Hold |
2,300
| – | – | ﹤0.01% | 98 |
|
|
2022
Q4 | $13.6K | Hold |
2,300
| – | – | ﹤0.01% | 93 |
|
|
2022
Q3 | $16K | Hold |
2,300
| – | – | ﹤0.01% | 155 |
|
|
2022
Q2 | $33K | Buy |
+2,300
| New | +$33K | 0.01% | 99 |
|